Orthocell Ltd
ASX:OCC

Watchlist Manager
Orthocell Ltd Logo
Orthocell Ltd
ASX:OCC
Watchlist
Price: 0.64 AUD -3.76% Market Closed
Market Cap: 153m AUD
Have any thoughts about
Orthocell Ltd?
Write Note

Orthocell Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Orthocell Ltd
Revenue Peer Comparison

Comparables:
MSB
CSL
CUV
TLX
PYC

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Orthocell Ltd
ASX:OCC
Revenue
AU$6.8m
CAGR 3-Years
77%
CAGR 5-Years
48%
CAGR 10-Years
N/A
Mesoblast Ltd
ASX:MSB
Revenue
$5.9m
CAGR 3-Years
-7%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Revenue
$14.8B
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
10%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Revenue
AU$95.5m
CAGR 3-Years
25%
CAGR 5-Years
25%
CAGR 10-Years
41%
Telix Pharmaceuticals Ltd
ASX:TLX
Revenue
AU$502.5m
CAGR 3-Years
359%
CAGR 5-Years
381%
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Revenue
AU$22.9m
CAGR 3-Years
93%
CAGR 5-Years
882%
CAGR 10-Years
42%

See Also

What is Orthocell Ltd's Revenue?
Revenue
6.8m AUD

Based on the financial report for Jun 30, 2024, Orthocell Ltd's Revenue amounts to 6.8m AUD.

What is Orthocell Ltd's Revenue growth rate?
Revenue CAGR 5Y
48%

Over the last year, the Revenue growth was 33%. The average annual Revenue growth rates for Orthocell Ltd have been 77% over the past three years , 48% over the past five years .

Back to Top